Terms: = Prostate cancer AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS AND Treatment
102 results:
1. Cumulative cancer locations on prostate biopsy and active surveillance outcomes in the MRI era.
Fletcher SA; Mamawala MM; Holler AE; Bhanji Y; Macura KJ; de la Calle CM; Pavlovich CP
Prostate; 2024 Jun; 84(8):723-730. PubMed ID: 38476030
[TBL] [Abstract] [Full Text] [Related]
2. Development of machine learning prognostic models for overall survival of prostate cancer patients with lymph node-positive.
Peng ZH; Tian JH; Chen BH; Zhou HB; Bi H; He MX; Li MR; Zheng XY; Wang YW; Chong T; Li ZL
Sci Rep; 2023 Oct; 13(1):18424. PubMed ID: 37891423
[TBL] [Abstract] [Full Text] [Related]
3. Does a patient-specific bladder-filling protocol affect bladder volume and dose in postprostatectomy radiotherapy?
Yalman D; Köylü M; Duran Ö
Int Urol Nephrol; 2024 Mar; 56(3):999-1006. PubMed ID: 37821762
[TBL] [Abstract] [Full Text] [Related]
4. The trajectory of sarcopenia following diagnosis of prostate cancer: A systematic review and meta-analysis.
Kovač MB; Pavlin T; Čavka L; Ribnikar D; Spazzapan S; Templeton AJ; Šeruga B
J Geriatr Oncol; 2023 Sep; 14(7):101594. PubMed ID: 37482497
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic biomarkers in the use of radium-223 in patients with metastatic castration-resistent prostate cancer.
Vidal M; Cárdenas-Perilla R; Delgado A; Morón S; Londoño Blair JL; Vega I; Correa Ochoa JJ; Rojas J
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(5):310-318. PubMed ID: 37419250
[TBL] [Abstract] [Full Text] [Related]
6. PARP1 negatively regulates transcription of blm through its interaction with HSP90AB1 in prostate cancer.
Huang M; Chen L; Guo Y; Ruan Y; Xu H
J Transl Med; 2023 Jul; 21(1):445. PubMed ID: 37415147
[TBL] [Abstract] [Full Text] [Related]
7. Implications of metastatic stage at presentation in docetaxel naïve metastatic castrate resistant prostate cancer.
Roy S; Wallis CJD; Morgan SC; Kishan AU; Le ATT; Malone J; Sun Y; Spratt DE; Saad F; Malone S
Prostate; 2023 Jul; 83(10):912-921. PubMed ID: 37071764
[TBL] [Abstract] [Full Text] [Related]
8. Impact of prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography on the Therapeutic Decision of prostate Carcinoma Primary Staging: A Retrospective Analysis at the Brazilian National Public Health System.
da Silva ACB; de Toledo LGM; de Carvalho Fernandes R; Ziroldo AR; Sawczyn GV; Alarcon ST; Lewin F
Ann Surg Oncol; 2023 Jul; 30(7):4541-4549. PubMed ID: 36995451
[TBL] [Abstract] [Full Text] [Related]
9. Median 4-year outcomes of salvage irreversible electroporation for localized radio-recurrent prostate cancer.
Geboers B; Scheltema MJ; Blazevski A; Katelaris A; Doan P; Ali I; Agrawal S; Barreto D; Matthews J; Haynes AM; Delprado W; Shnier R; Thompson JE; Stricker PD
BJU Int; 2023 Jun; 131 Suppl 4():14-22. PubMed ID: 36594205
[TBL] [Abstract] [Full Text] [Related]
10. A prospective, multicenter head-to-head comparative study in patients with primary high-risk prostate cancer investigating the bone lesion detection of conventional imaging and
Bodar YJL; Luining WI; Keizer B; Meijer D; Vellekoop A; Schaaf M; Hendrikse NH; Van Moorselaar RJA; Oprea-Lager DE; Vis AN
Urol Oncol; 2023 Apr; 41(4):205.e17-205.e24. PubMed ID: 36588019
[TBL] [Abstract] [Full Text] [Related]
11. Discovery of a Novel Bloom's Syndrome Protein (blm) Inhibitor Suppressing Growth and Metastasis of prostate cancer.
Ma XY; Xu HQ; Zhao JF; Ruan Y; Chen B
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499126
[TBL] [Abstract] [Full Text] [Related]
12. N
Chen B; Liu C; Long H; Bai G; Zhu Y; Xu H
Int J Oncol; 2023 Jan; 62(1):. PubMed ID: 36484368
[TBL] [Abstract] [Full Text] [Related]
13. Role of
Sopeña Sutil R; Gómez Grande A; González Díaz A; Téigel Tobar J; Cabeza Rodríguez MÁ; González Billalabeitia E; Rodríguez Antolín A
Arch Esp Urol; 2022 Oct; 75(8):684-692. PubMed ID: 36330569
[TBL] [Abstract] [Full Text] [Related]
14. Association of 5α-Reductase Inhibitors With prostate cancer Mortality.
Björnebo L; Nordström T; Discacciati A; Palsdottir T; Aly M; Grönberg H; Eklund M; Lantz A
JAMA Oncol; 2022 Jul; 8(7):1019-1026. PubMed ID: 35587340
[TBL] [Abstract] [Full Text] [Related]
15. prostate arterial chemoembolization for treatment of refractory hematuria and urinary retention in patients with localized advanced prostate cancer.
Wang MQ; Zhang JL; Duan F; Yuan B; Xin H; Fu JX; Ye HY; Yu HK; Feng DP; Cheng K; Zhang XJ
Prostate Cancer Prostatic Dis; 2023 Mar; 26(1):88-95. PubMed ID: 35249108
[TBL] [Abstract] [Full Text] [Related]
16. Influence of androgen deprivation therapy on the severity of COVID-19 in prostate cancer patients.
Jiménez-Alcaide E; García-Fuentes C; Hernández V; De la Peña E; Pérez-Fernández E; Castro A; Caballero-Perea B; Guijarro A; Llorente C
Prostate; 2021 Dec; 81(16):1349-1354. PubMed ID: 34517429
[TBL] [Abstract] [Full Text] [Related]
17. The prognostic value of digital rectal exam for the existence of advanced pathologic features after prostatectomy.
Prebay ZJ; Medairos R; Doolittle J; Langenstroer P; Jacobsohn K; See WA; Johnson SC
Prostate; 2021 Oct; 81(14):1064-1070. PubMed ID: 34297858
[TBL] [Abstract] [Full Text] [Related]
18. Nuclear Export Inhibitor KPT-8602 Synergizes with PARP Inhibitors in Escalating Apoptosis in Castration Resistant cancer Cells.
Uddin MH; Li Y; Khan HY; Muqbil I; Aboukameel A; Sexton RE; Reddy S; Landesman Y; Kashyap T; Azmi AS; Heath EI
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206543
[TBL] [Abstract] [Full Text] [Related]
19. KEYNOTE-641: a Phase III study of pembrolizumab plus enzalutamide for metastatic castration-resistant prostate cancer.
Graff JN; Liang LW; Kim J; Stenzl A
Future Oncol; 2021 Aug; 17(23):3017-3026. PubMed ID: 34044584
[TBL] [Abstract] [Full Text] [Related]
20. Response evaluation of bone metastasis in prostate cancer: Preliminary comparison of computerized bone scan index versus standardized clinical criteria.
Petersen LJ; Gade M; Fonager RF; Albertsen S; Fledelius J; Ejlersen JA; Christensen MH; Aleksyniene R; Zacho HD
Hell J Nucl Med; 2021; 24(1):2-9. PubMed ID: 33866333
[TBL] [Abstract] [Full Text] [Related]
[Next]